Picture of Amoeba SA logo

ALMIB Amoeba SA News Story

0.000.00%
fr flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapSucker Stock

Brief: Amoeba Announces Results Of A Laboratory Safety And Efficacy Study

Nov 7 (Reuters) - AMOEBA SA  AMEBA.PA :
    * AMOEBA ANNOUNCES THE RESULTS OF A SAFETY & EFFICACY STUDY
ASSESSING THE FATE OF LEGIONELLA PNEUMOPHILA IN WILLAERTIA MAGNA
C2C MAKY.
    * A STRONG EFFICACY OF WILLAERTIA MAGNA C2C MAKY TO
ELIMINATE THE
LEGIONELLA
    * AN ABSENCE OF LEGIONELLA MULTIPLICATION IN WILLAERTIA
MAGNA C2C
MAKY, AT ANY TIME.
    * AFTER 4 DAYS, COMPLETE ABSENCE OF CULTURABLE BACTERIA IN
WILLAERTIA MAGNA C2C MAKY INFECTED WITH LEGIONELLA, SHOWING THE
ABSENCE OF LEGIONELLA SURVIVAL
    * ON THE CONTRARY, A MULTIPLICATION OF LEGIONELLA IN
WILLAERTIA
MAGNA Z503 AND IN ACANTHAMOEBA CASTELLANII RESULTS IN ACCORDANCE
WITH PUBLISHED SCIENTIFIC LITERATURE
    * ANY LEGIONELLA PNEUMOPHILA PHILADELPHIA INGESTED BY
WILLAERTIA
MAGNA C2C MAKY WILL IN FINE BE DIGESTED

Source text: https://bit.ly/2JM7LGa
Further company coverage:  AMEBA.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Amoeba SA

See all news